Chief Medical Officer · InnovAge Holding Corp. (INNV)

Richard Feifer

FY2023 is the first fiscal year CompBrief holds for Richard Feifer as a named executive officer of InnovAge; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$1,338,689

Salary $351,667Stock awards $800,008

3rd of 3 named executive officers at InnovAge by FY2023 total.

3 named officers on file for InnovAge, FY2023

Richard Feifer’s pay file — $29

  • 1 fiscal year of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how InnovAge’s whole pay program stands against its peers

  • InnovAge’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on INNV→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed October 27, 2023 (DEF 14A). Insider transactions since that proxy, current to 2026-11-20.

Free

Get Richard Feifer’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Richard Feifer compensation by year

InnovAge Summary Compensation Table · the one fiscal year held
In US dollars, as InnovAge reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023
Salary$351,667
Bonus$0
Stock awards$800,008
Option awards$0
Non-equity incentive$183,014
Pension and deferred compensation$0
All other$4,000
Total$1,338,689

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: InnovAge Holding Corp. DEF 14A filed October 27, 2023, accession 0001140361-23-049848, and prior-year filings. Open the filing on EDGAR.

How this page was built: the InnovAge Holding Corp. filed document, accession 0001140361-23-049848. Every figure is read from that document and cited to the page and table it appears in. Filed October 27, 2023.

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
RSU92,593$694,448—
RSU52,152$391,140—

Per the Outstanding Equity Awards at Fiscal Year-End table in InnovAge Holding Corp.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

3 Form 4 lines since the FY2023 proxy (filed October 27, 2023)
current to 2026-11-20 · updated nightly
DateTransactionPlanSharesPriceHeld after
2024-08-15Tax withholding—14,303$6.22220,908
2024-06-06Tax withholding—8,023$4.83235,211
2024-06-04Grant or award—108,226$0.00243,234

The 3 most recent of 3 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

InnovAge’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Patrick BlairPresident and Chief Executive Officer$1,506,600
Nicole D’AmatoChief Legal Officer and Corporate Secretary$1,478,770
Richard Feifer · this pageChief Medical Officer$1,338,689

The full InnovAge compensation record

free company brief

This page is one person within InnovAge's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are InnovAge's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Richard Feifer's compensation dossier · One-time report. No refunds.